27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
F-Star Therapeutics Inc (NASDAQ:FSTX) shares are trading higher Tuesday after the company announced clearance for the proposed acquisition by invoX Pharma.
What To Know: The Committee on Foreign Investment in the United States (CFIUS) has cleared the previously announced acquisition by invoX Pharma, marking the final required regulatory approval needed to complete the proposed merger.
The merger is expected to be completed following the successful completion of the ongoing tender offer. The offer is scheduled to expire Wednesday at 5 p.m. ET.
F-Star is a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer.
See Also: Virax Biolabs Stock Soars On Avian Flu Test Kit Agreement: What's Going On?
FSTX Price Action: F-Star has a 52-week high of $6.93 and a 52-week low of $2.07.
The stock was up 16.6% at $7.11 at time of publication, according to Benzinga Pro.
Photo: Lorenzo Cafaro from Pixabay.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!